ACAN and osteoarthritis: By binding aggrecan to stable complexes, HA helps protect aggrecan from enzymatic degradation owing to the effects of enzymes typical of osteoarthritis, such as aggrecanases and matrix metalloproteinases (MMPs), which are elevated and degrade ECM components, including aggrecan [95].